| 2024 | Application of the 2022 ACR/EULAR criteria for Takayasu arteritis to previously diagnosed patients based on the 1990 ACR criteria | MODERN RHEUMATOLOGY |
| 2024 | Overlap syndrome of systemic sclerosis with antineutrophil cytoplasmic antibody-associated vasculitis according to 2022 ACR/EULAR criteria
| KOREAN JOURNAL OF INTERNAL MEDICINE |
| 2024 | Circulating cold-inducible RNA-binding protein levels in microscopic polyangiitis and granulomatosis with polyangiitis : Correlation with disease activity | ZEITSCHRIFT FUR RHEUMATOLOGIE |
| 2024 | Birmingham vasculitis activity score and the short form 36-item health survey predict current depressive disorders in patients with antineutrophil cytoplasmic antibody-associated vasculitis during the SARS-CoV-2 pandemic
| ZEITSCHRIFT FUR RHEUMATOLOGIE |
| 2024 | Antineutrophil cytoplasmic antibody-associated vasculitis classification by cluster analysis based on clinical phenotypes: a single-center retrospective cohort study | CLINICAL RHEUMATOLOGY |
| 2023 | Soluble triggering receptor expressed on myeloid cell-1 reflects the cross-sectional activity of microscopic polyangiitis and granulomatosis with polyangiitis
| HELIYON |
| 2023 | Lung function trajectory of rheumatoid arthritis-associated interstitial lung disease
| RHEUMATOLOGY |
| 2023 | Renal histopathological predictors of end-stage kidney disease in ANCA-associated vasculitis with glomerulonephritis: a single-centre study in Korea
| SCIENTIFIC REPORTS |
| 2023 | Acute Brain Infarction in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Korean Single-Center Study | JCR-JOURNAL OF CLINICAL RHEUMATOLOGY |
| 2023 | A prognostic immune nutritional index can predict all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis
| THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE |
| 2023 | Predictive potential of albumin-alkaline phosphatase ratio for cerebrovascular accident in patients with antineutrophil cytoplasmic antibody-associated vasculitis | ANNALS OF CLINICAL BIOCHEMISTRY |
| 2023 | New index using triglyceride glucose-body mass index for predicting mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis
| FRONTIERS IN MEDICINE |
| 2023 | BNT162b2 접종과 면역관문억제제 치료 이후 발생한 이상 반응 1예
| Korean Journal of Medicine |
| 2023 | Soluble Tyro-3 and Axl may reflect the current activity and renal involvement in patients with microscopic polyangiitis and granulomatosis with polyangiitis
| CLINICAL AND EXPERIMENTAL RHEUMATOLOGY |
| 2023 | Serum soluble interleukin-7 receptor alpha levels are negatively correlated with the simultaneous activity of antineutrophil cytoplasmic antibody-associated vasculitis
| CLINICAL AND EXPERIMENTAL RHEUMATOLOGY |
| 2023 | Application of the 2022 ACR/EULAR criteria for microscopic polyangiitis to patients with previously diagnosed microscopic polyangiitis
| CLINICAL AND EXPERIMENTAL RHEUMATOLOGY |
| 2023 | Reclassification of previously diagnosed GPA patients using the 2022 ACR/EULAR classification criteria | RHEUMATOLOGY |
| 2023 | The Reclassification of Patients With Previously Diagnosed Eosinophilic Granulomatosis With Polyangiitis Based on the 2022 ACR/EULAR Criteria for Antineutrophil Cytoplasmic Antibody-Associated Vasculitis | JOURNAL OF RHEUMATOLOGY |
| 2023 | Implication of Serious Infections in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis for the First Cycle of Rituximab: A Pilot Study in a Single Korean Center
| Journal of Rheumatic Diseases |
| 2023 | Cancer-associated vasculitides: a single-centre case series | CLINICAL RHEUMATOLOGY |
| 2023 | Comparison of the 2022 ACR/EULAR Classification Criteria for Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Previous Criteria
| YONSEI MEDICAL JOURNAL |
| 2022 | 건강보험 청구자료를 이용한 한국인 염증성 관절염 환자의 뇌졸중 발생 분석
| Korean Journal of Clinical Geriatrics(임상노인의학회지) |
| 2022 | Soluble immune checkpoint molecules in patients with antineutrophil cytoplasmic antibody-associated vasculitis
| SCIENTIFIC REPORTS |
| 2022 | A retrospective analysis of the relationship between anti-cyclic citrullinated peptide antibody and interstitial lung disease in systemic sclerosis
| SCIENTIFIC REPORTS |
| 2022 | Interferon-gamma Release Assay Results Are Reliable for Screening for Latent Tuberculosis in Antineutrophil Cytoplasmic Antibody-associated Vasculitis
| IN VIVO |
| 2022 | Clinical impact of antineutrophil cytoplasmic antibody positivity on the occurrence of interstitial lung disease in patients with polymyositis/dermatomyositis
| ANNALS OF PALLIATIVE MEDICINE |
| 2022 | Serum glycated albumin as a predictive biomarker for renal involvement of antineutrophil cytoplasmic antibody-associated vasculitis in non-diabetic patients
| BMC NEPHROLOGY |
| 2022 | Nutrition Risk Index Score at Diagnosis Can Effectively Predict Poor Prognosis in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis | JOURNAL OF RENAL NUTRITION |
| 2022 | Modified Body Mass Index at Diagnosis is a Useful Predictor of Mortality in Patients With Antineutrophil Cytoplasmic Antibody-associated Vasculitis
| Journal of Rheumatic Diseases |
| 2022 | Predicting the depressive status using empirical dietary inflammatory index in patients with antineutrophil cytoplasmic antibody-associated vasculitis
| JOURNAL OF CLINICAL LABORATORY ANALYSIS |
| 2022 | Fatty Liver Index Independently Predicts All-Cause Mortality in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis but No Substantial Liver Disease
| FRONTIERS IN CARDIOVASCULAR MEDICINE |
| 2022 | Triglyceride and Glucose Index Predicts Acute Coronary Syndrome in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
| DIAGNOSTICS |
| 2022 | Serum galectin-9 could be a potential biomarker in assessing the disease activity of antineutrophil cytoplasmic antibody-associated vasculitis
| CLINICAL AND EXPERIMENTAL RHEUMATOLOGY |
| 2022 | Effect of numbers of metabolic syndrome components on mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis with metabolic syndrome
| CLINICAL AND EXPERIMENTAL RHEUMATOLOGY |
| 2022 | New body mass index for predicting prognosis in patients with antineutrophil cytoplasmic antibody-associated vasculitis
| JOURNAL OF CLINICAL LABORATORY ANALYSIS |
| 2022 | Incidence and Patterns of Interstitial Lung Disease and Their Clinical Impact on Mortality in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Korean Single-Centre Observational Study
| JOURNAL OF IMMUNOLOGY RESEARCH |
| 2022 | Anti-Citrullinated Peptide Antibody Expression and Its Association with Clinical Features and Outcomes in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
| MEDICINA-LITHUANIA |
| 2022 | A retrospective analysis of antineutrophil cytoplasmic antibody-associated vasculitis aiming for an equation prediction end-stage renal disease | CLINICAL RHEUMATOLOGY |
| 2022 | Serum vitamin D level correlates with disease activity and health-related quality of life in antineutrophil cytoplasmic antibody-associated vasculitis | ZEITSCHRIFT FUR RHEUMATOLOGIE |
| 2022 | Association Between Idiopathic Cutaneous Leukocytoclastic Angiitis and ANCA-negative Microscopic Polyangiitis
| Journal of Rheumatic Diseases |
| 2021 | Metabolic Syndrome Severity Score, Comparable to Serum Creatinine, Could Predict the Occurrence of End-Stage Kidney Disease in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
| JOURNAL OF CLINICAL MEDICINE |
| 2021 | Serum progranulin as a predictive marker for high activity of antineutrophil cytoplasmic antibody-associated vasculitis
| JOURNAL OF CLINICAL LABORATORY ANALYSIS |
| 2021 | Serum Clusterin Level Could Reflect the Current Activity of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
| YONSEI MEDICAL JOURNAL |
| 2021 | Clinical significance of large unstained cell count in estimating the current activity of antineutrophil cytoplasmic antibody-associated vasculitis | INTERNATIONAL JOURNAL OF CLINICAL PRACTICE |
| 2021 | Correlation between serum cysteine-rich protein 61 and disease activity of antineutrophil cytoplasmic antibody-associated vasculitis | CLINICAL RHEUMATOLOGY |
| 2021 | Efficacy of tacrolimus as maintenance therapy after cyclophosphamide for treating antineutrophil cytoplasmic antibody-associated vasculitis
| MEDICINE |
| 2021 | Systemic inflammation response index predicts all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis | INTERNATIONAL UROLOGY AND NEPHROLOGY |
| 2021 | Significance of antineutrophil cytoplasmic antibody positivity in patients with systemic sclerosis: a single-centre pilot study in Korea | CLINICAL AND EXPERIMENTAL RHEUMATOLOGY |
| 2021 | Predictive Ability of Serum IL-27 Level for Assessing Activity of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
| MEDIATORS OF INFLAMMATION |
| 2021 | The Efficacy of Mycophenolate Mofetil in Remission Maintenance Therapy for Microscopic Polyangiitis and Granulomatosis with Polyangiitis
| YONSEI MEDICAL JOURNAL |
